MK801 Reduces Secondary Injury in Spinal Cord Trauma in Mice
Author Information
Author(s): Esposito Emanuela, Paterniti Irene, Mazzon Emanuela, Genovese Tiziana, Galuppo Maria, Meli Rosaria, Bramanti Placido, Cuzzocrea Salvatore
Primary Institution: University of Messina, Italy
Hypothesis
The study investigates the neuroprotective effect of MK801 in a mouse model of spinal cord injury.
Conclusion
MK801 treatment significantly reduces inflammation and improves recovery of locomotor function after spinal cord injury.
Supporting Evidence
- MK801 treatment reduced the levels of inflammatory cytokines TNF-α and IL-1β.
- Histological analysis showed reduced tissue damage in MK801-treated mice.
- Motor function recovery was significantly improved in mice treated with MK801.
Takeaway
This study shows that a drug called MK801 can help protect the spinal cord and improve movement after an injury.
Methodology
The study used a mouse model of spinal cord injury induced by compression, with treatment of MK801 administered at specific time points after injury.
Participant Demographics
Male adult CD1 mice, 25-30 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website